Se connecter
Intranet
Thème

Biographie pas encore disponible.

Publications

2024
2024
Gwenaëlle Jézéquel, Zoé Grimanelli, Carole Guimard, Joëlle Bigay, Juliano Haddad, Jérôme Bignon, Cécile Apel, Vincent Steinmetz, Laurie Askenatzis, Hélène Levaïque, Clara Pradelli, Van Cuong Pham, Thi May Huong Doan, Marc Litaudon, Romain Gautier, Chaker El Kalamouni, Bruno Antonny, Sandy Desrat, Bruno Mesmin, Fanny Roussi, Bio-inspired synthesis and profiling of a potent antiviral flavonol targeting the lipid exchanger OSBP, 2024.
2023
2023
2023
2022
Maitra S, Vincent B, Cdk5-p25 as a key element linking amyloid and tau pathologies in Alzheimer’s disease: Mechanisms and possible therapeutic interventions., Life Sci 2022 Nov; 308(): 120986.
2022
Subhamita Maitra, Bruno Vincent, ADAM10 pharmacological inhibition modifies the expression of components of the dopaminergic system, 2023.
2022
2022
2021
2021
2021
2019
2019
2019
2017
2017
Htoo HH, Limsuvan S, Thamsermsang O, Hernandez JF, Checler F, Govitrapong P, Pakaprot N, Akarasereenont P, Vincent B, The Polyherbal Wattana Formula Displays Anti-Amyloidogenic Properties by Increasing α-Secretase Activities., PLoS One 2017 ; 12(1): e0170360.
2016
2013
2013
2011
2011
Cissé M, Duplan E, Guillot-Sestier MV, Rumigny J, Bauer C, Pagès G, Orzechowski HD, Slack BE, Checler F, Vincent B, The extracellular regulated kinase-1 (ERK1) controls regulated alpha-secretase-mediated processing, promoter transactivation, and mRNA levels of the cellular prion protein., J Biol Chem 2011 Aug; 286(33): 29192-29206.
2010
2008
2007
Frédéric Checlerc, Moustapha Alfa Cissé, Claire Sunyach, Babara E Slack, Céline Gandreuil, Jean-François Hernandez, Jean Martinez, Abraham Fisher, Bruno Vincent, Les récepteurs muscariniques M1 et M3 induisent le métabolisme physiologique de la PrPc et de la ßAPP en modulant la phosphorylation et l’activité d’ADAM 17, 9ème Réunion francophone sur la maladie d'Alzheimer et les syndromes apparentés, Nov 2007, Nice, France.
2007
Checler F, Sunyach C, Pardossi-Piquard R, Sévalle J, Vincent B, Kawarai T, Girardot N, St George-Hyslop P, da Costa CA, The gamma/epsilon-secretase-derived APP intracellular domain fragments regulate p53., Curr Alzheimer Res 2007 Sep; 4(4): 423-6.
2007
2007
Pardossi-Piquard R, Dunys J, Kawarai T, Sunyach C, Alves da Costa C, Vincent B, Sévalle J, Pimplikar S, St George-Hyslop P, Checler F, Response to correspondence: Pardossi-Piquard et al., « Presenilin-dependent transcriptional control of the Abeta-degrading enzyme neprilysin by intracellular domains of betAAPP and APLP. » Neuron 46, 541-554., Neuron 2007 Feb; 53(4): 483-6.
2006
Alves da Costa C, Sunyach C, Pardossi-Piquard R, Sévalle J, Vincent B, Boyer N, Kawarai T, Girardot N, St George-Hyslop P, Checler F, Presenilin-dependent gamma-secretase-mediated control of p53-associated cell death in Alzheimer’s disease., J Neurosci 2006 Jun; 26(23): 6377-85.
2006
J. Eschbach, D. Rouxel, B. Vincent, Yannick Mugnier, Christine Galez, O. Elmazria, P. Alnot, Development and characterization of nanocomposite materials, Nanostructured and functional polymer-based materials and composites, May 2006, Lyon, France.
2005
R. Pardossi-Piquard, A. Petit, T. Kawarai, C. Sunyach, C. Alves da Costa, B. Vincent, S. Ring, L. d'Adamio, J. Shen, U. Müller, P. St George-Hyslop P., F. Checler, Presenilin-dependent transcriptional control of the Ab-degrading enzyme neprilysin by intracellular domains of bAPP and APLP, Neuron, 2005, 46, pp.551-554.
2004
E. Paitel, C. Sunyach, C. Alves da Costa, J.C. Bourdon, B. Vincent, F. Checler, Primary cultured neurons devoid of cellular prion display lower responsiveness to staurosporine through the control of p53 at both transcriptional and post-transcriptional levels., Journal of Biological Chemistry, 2004, 279, pp.612-618.
2001
Armogida M, Petit A, Vincent B, Scarzello S, da Costa CA, Checler F, Endogenous beta-amyloid production in presenilin-deficient embryonic mouse fibroblasts., Nat Cell Biol 2001 Nov; 3(11): 1030-3.
1997
Vincent B, Jiracek J, Noble F, Loog M, Roques B, Dive V, Vincent JP, Checler F, Effect of a novel selective and potent phosphinic peptide inhibitor of endopeptidase 3.4.24.16 on neurotensin-induced analgesia and neuronal inactivation., Br J Pharmacol 1997 Jun; 121(4): 705-10.
1996
Vincent B, Vincent JP, Checler F, Purification and characterization of human endopeptidase 3.4.24.16. Comparison with the porcine counterpart indicates a unique cleavage site on neurotensin., Brain Res 1996 Feb; 709(1): 51-8.
1993
Checler F, Barelli H, Dauch P, Vincent B, Dive V, Beaudet A, Daniel EE, Fox-Threlkeld JE, Masuo Y, Vincent JP, Recent advances on endopeptidase-3.4.24.16., Biochem Soc Trans 1993 Aug; 21 ( Pt 3)(3): 692-7.
1993
Barelli H, Mao YK, Vincent B, Daniel EE, Vincent JP, Checler F, Differential catabolic fate of neuromedin N and neurotensin in the canine intestinal mucosa., Peptides 1993 ; 14(3): 457-63.